Canada· CA-DIN-02530422
THE SOLUTION ANORECTAL SPRAY TEMPORARY PAIN RELIEF
A lidocaine product containing lidocaine hydrochloride + epinephrine (epinephrine hydrochloride), registered in Canada by SCALP TECH INC.. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Lidocaine is registered in 11 of 19 countries.
Countries holding a registration under ATC D04AB01 (lidocaine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Lidocaine · ATC D04AB01
11 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LIDOCAINE HYDROCHLORIDE + EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE)
- Manufacturer
- SCALP TECH INC.
- Country
- Canada (CA)
- ATC code
- D04AB01
- ATC class
- Lidocaine
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
39 interactions on record for lidocaine.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lidocaine · interactions on record
39 records
- 1 severe
- 38 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- Glyceryl trinitrateC01DA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lidocaine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsLidocaïne/Adrenaline Aguettant 10 mg/ml + 5 microgram/ml oplossing voor injectieLaboratoire Aguettant
- SpainLIDOCAINA /ADRENALINA AGUETTANT 20 MG/ML + 0,005 MG/ML SOLUCION INYECTABLE EFGLaboratoire Aguettant
- NorwayXylocain AdrenalinAspen Pharma Trading Limited
- FranceLIDOCAÏNE 10 mg/ml ADRENALINE 0,005 mg/ml AGUETTANT, solution injectableAGUETTANT
- IcelandLidentLaboratorios Normon, S.A.
- IrelandLignospan Special (20 mg/12.5 microgram per ml) Solution for Injection 1.8 mlSeptodont
- GermanyXylocitin Mit Epinephrin (Adrenalin)Mibe Gmbh Arzneimittel
- SwedenXylocain adrenalin 10 mg/ml + 5 mikrogram/ml Injektionsvätska, lösningAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Xylocaine Adrenaline, Xylocaine Adrénaline
- Germany · Xylocitin Mit Epinephrin (Adrenalin)
- Denmark · Xylocain
- Spain · Lidocaína / Epinefrina Dermogen, Lidocaína/Epinefrina Normon
- France · Epinephrine, Lidocaine Hydrochloride Aguettant, Xylocaine
- United Kingdom (Northern Ireland) · Lidocaine With Adrenaline (Epinephrine) Aspen Pharma
- Ireland · Xylocaine With Adrenaline (Epinephrine)
- Iceland · Xylocain Adrenalin
- Italy · Ecocain
- Luxembourg · Lignospan, Xylocaine Adrenaline
- Netherlands · Xylocaine Adrenaline
- Norway · Xylocain Adrenalin
- Portugal · Lidocaína Adrenalina Labesfal, Octocaine
- Sweden · Xylocain Adrenalin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb6f4033-883b-4c06-a095-e1d69a1f2fa7 GET /v1/drugs/bb6f4033-883b-4c06-a095-e1d69a1f2fa7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02530422",
"form": "SPRAY",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "D04AB01",
"schedule": [
"OTC"
],
"drug_code": "101961",
"strengths": [
"5 %",
"0.01 %"
],
"ahfs_class": null,
"substances": [
"LIDOCAINE HYDROCHLORIDE",
"EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE)"
],
"product_categorization": "LS - ANORECTAL DRUG PRODUCTS"
}See everything about lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.